Αlbendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Albendazole is the active ingredient of these drugs:
Brazil
Singapore
Brazil
United States
Singapore
Lithuania
Australia Austria France Lithuania Netherlands
Lithuania
Brazil
Brazil
Tunisia
Brazil
Tunisia
Tunisia
Australia France Singapore
Cyprus
Brazil